DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Amato RJ, Wood LS, Savary C.
Patients with renal cell carcinoma (RCC) using autologous
tumor-derived heat shock protein-peptide complex (HSPPC-96) with or without
interleukin-2 (IL-2) (abstract).
Proc Am Soc Clin Oncol 2000; 19: 454a-
We do not assume any responsibility for the contents of the web pages of other providers.